688185 康希诺
已收盘 04-26 15:00:00
资讯
新帖
简况
康希诺生物盘中异动 股价大涨5.20%报19.000港元
自选股智能写手 · 04-25
康希诺生物盘中异动 股价大涨5.20%报19.000港元
北向资金4月24日净买入康希诺2.33万股 连续3日增持
自选股智能写手 · 04-25
北向资金4月24日净买入康希诺2.33万股 连续3日增持
康希诺（688185）4月24日主力资金净卖出291.22万元
证券之星 · 04-25
康希诺（688185）4月24日主力资金净卖出291.22万元
康希诺（688185）4月23日主力资金净卖出124.72万元
证券之星 · 04-24
康希诺（688185）4月23日主力资金净卖出124.72万元
康希诺04月23日遭主力抛售155万元 环比增加127.94%
自选股智能写手 · 04-23
康希诺04月23日遭主力抛售155万元 环比增加127.94%
康希诺生物(06185): Hib疫苗获批准开展临床试验，重组肺炎球菌蛋白疫苗I期试验见成效
和讯网 · 04-23
康希诺生物(06185): Hib疫苗获批准开展临床试验，重组肺炎球菌蛋白疫苗I期试验见成效
生物疫苗概念盘中跳水，康希诺跌0.02%
自选股智能写手 · 04-23
生物疫苗概念盘中跳水，康希诺跌0.02%
南向资金4月22日净买入康希诺生物13.26万股 连续7日增持
自选股智能写手 · 04-23
南向资金4月22日净买入康希诺生物13.26万股 连续7日增持
康希诺(688185.SH)：Hib疫苗临床试验获批
智通财经 · 04-22
康希诺(688185.SH)：Hib疫苗临床试验获批
康希诺： 为关于公司流脑产品就特定内容的进一步补充申报，如有阶段性进展，会及时分享
证券之星 · 04-22
康希诺： 为关于公司流脑产品就特定内容的进一步补充申报，如有阶段性进展，会及时分享
康希诺董秘回复： 基于四价流脑结合疫苗的高端市场定位，销售和市场拓展方面
证券之星 · 04-22
康希诺董秘回复： 基于四价流脑结合疫苗的高端市场定位，销售和市场拓展方面
【AH互动】康希诺(06185)AH股齐升逾4% 重组肺炎球菌蛋白疫苗I期临床试验取得积极初步结果
金吾财讯 · 04-22
【AH互动】康希诺(06185)AH股齐升逾4% 重组肺炎球菌蛋白疫苗I期临床试验取得积极初步结果
康希诺生物盘中异动 早盘股价大涨5.09%
自选股智能写手 · 04-22
康希诺生物盘中异动 早盘股价大涨5.09%
康希诺大幅上涨 近半年3家券商看好
智选洞察 · 04-22
康希诺大幅上涨 近半年3家券商看好
I期临床试验成功！康希诺生物重组肺炎球菌蛋白疫苗研发取得积极成果，为全球疫苗市场带来新希望
和讯网 · 04-21
I期临床试验成功！康希诺生物重组肺炎球菌蛋白疫苗研发取得积极成果，为全球疫苗市场带来新希望
1期临床大捷：康希诺重组肺炎球菌蛋白疫苗展现广谱潜力
和讯网 · 04-21
1期临床大捷：康希诺重组肺炎球菌蛋白疫苗展现广谱潜力
南向资金4月18日净买入康希诺生物8.24万股 连续5日增持
自选股智能写手 · 04-19
南向资金4月18日净买入康希诺生物8.24万股 连续5日增持
北向资金4月18日净卖出康希诺1.61万股 连续3日减持
自选股智能写手 · 04-19
北向资金4月18日净卖出康希诺1.61万股 连续3日减持
康希诺生物盘中异动 下午盘急速拉升5.01%
自选股智能写手 · 04-17
康希诺生物盘中异动 下午盘急速拉升5.01%
康希诺04月16日主力资金流出169万元 连续3日减仓
自选股智能写手 · 04-16
康希诺04月16日主力资金流出169万元 连续3日减仓
公司概况
公司名称：
康希诺生物股份公司
所属行业：
医药制造业
上市日期：
2020-08-13
主营业务：
康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。
发行价格：
209.71
{"stockData":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":49.3,"timestamp":1714114800000,"preClose":48.01,"halted":0,"volume":1381054,"delay":0,"floatShares":114999999,"shares":247000000,"eps":-8.3089,"marketStatus":"已收盘","marketStatusCode":5,"change":1.29,"latestTime":"04-26 15:00:00","open":48.44,"high":49.38,"low":47.8,"amount":67467800,"amplitude":0.0329,"askPrice":49.3,"askSize":4,"bidPrice":49.27,"bidSize":15,"shortable":0,"etf":0,"ttmEps":-8.3089,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714354200000},"adr":0,"adjPreClose":48.01,"symbolType":"stock_kcb","openAndCloseTimeList":[[1714095000000,1714102200000],[1714107600000,1714114800000]],"highLimit":52.81,"lowLimit":43.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":247449899,"pbRate":2.31,"roa":"--","roe":"--","epsLYR":-6.01,"committee":0.44,"marketValue":12199000000,"floatMarketCap":5659000000,"peRate":-5.933397,"changeRate":0.0269,"turnoverRate":0.012,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-04-29。","afterMarket":{"amount":0,"volume":0,"close":49.3,"buyVolume":0,"sellVolume":0,"time":1714116839505,"indexStatus":"已收盘 04-26 15:30:00","preClose":48.01}},"requestUrl":"/m/hq/s/688185/wiki","defaultTab":"wiki","newsList":[{"id":"2430448066","title":"康希诺生物盘中异动 股价大涨5.20%报19.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430448066","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430448066?lang=zh_cn&edition=full","pubTime":"2024-04-25 11:03","pubTimestamp":1714014192,"startTime":"0","endTime":"0","summary":"2024年04月25日早盘11时03分，康希诺生物股票出现异动，股价快速拉升5.20%。截至发稿，该股报19.000港元/股，成交量65.38万股，换手率0.49%，振幅6.53%。资金方面，该股资金流入749.997万港元，流出278.352万港元。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体涨幅为1.15%。消息层面，截至11时03分，康希诺生物股票正面舆情新闻比例20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042511031279233783&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042511031279233783&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430411725","title":"北向资金4月24日净买入康希诺2.33万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430411725","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430411725?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:30","pubTimestamp":1714008632,"startTime":"0","endTime":"0","summary":"4月24日, 北向资金增持康希诺2.33万股，连续3日增持。截止当日收盘，沪股通共持有康希诺81.82万股，占流通股0.71%。沪股通增持金额前五个股分别为中国平安、海尔智家、农业银行、招商银行、万华化学。康希诺近5个交易日上涨1.18%，沪股通累计增持0.47万股；近20个交易日下跌6.52%，沪股通累计减持62.62万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404250935598b50eb24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404250935598b50eb24&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430138704","title":"康希诺（688185）4月24日主力资金净卖出291.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430138704","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430138704?lang=zh_cn&edition=full","pubTime":"2024-04-25 07:53","pubTimestamp":1714002790,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月24日收盘，康希诺报收于47.86元，下跌1.22%，换手率1.03%，成交量1.18万手，成交额5648.44万元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入467.68万元，融资偿还295.66万元，融资净买入172.02万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500013491.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429124827","title":"康希诺（688185）4月23日主力资金净卖出124.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429124827","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429124827?lang=zh_cn&edition=full","pubTime":"2024-04-24 07:46","pubTimestamp":1713915972,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月23日收盘，康希诺报收于48.45元，上涨2.78%，换手率1.27%，成交量1.46万手，成交额7031.08万元。近5日资金流向一览见下表：康希诺融资融券信息显示，融资方面，当日融资买入472.33万元，融资偿还368.57万元，融资净买入103.76万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400013338.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429152676","title":"康希诺04月23日遭主力抛售155万元 环比增加127.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429152676","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429152676?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:18","pubTimestamp":1713856720,"startTime":"0","endTime":"0","summary":"04月23日, 康希诺股价涨2.78%，报收48.45元，成交金额7031万元，换手率1.27%，振幅4.03%，量比1.08。康希诺今日主力资金净流出155万元，连续3日净流出，上一交易日主力净流出68万元，今日环比增加127.94%。该股近5个交易日上涨6.27%，主力资金累计净流出1000万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1672万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231529078b498437&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231529078b498437&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429307971","title":"康希诺生物(06185): Hib疫苗获批准开展临床试验，重组肺炎球菌蛋白疫苗I期试验见成效","url":"https://stock-news.laohu8.com/highlight/detail?id=2429307971","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2429307971?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:10","pubTimestamp":1713849045,"startTime":"0","endTime":"0","summary":"快讯正文康希诺生物股价今日大涨，最高涨幅接近6%。截至发稿时，公司股价攀升4.69%，报收于18.32港元，成交额达到830.79万港元。根据公司公告，康希诺生物研发的冻干b型流感嗜血杆菌结合疫苗已成功获得国家药监局的批准，即将展开相关临床试验。此外，该公司近期还公布了其研发的重组肺炎球菌蛋白疫苗在I期临床试验中取得的积极初步结果。基于I期临床试验的初步成果，康希诺生物计划进行下一阶段的PBPV研发工作评估与规划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313424387a467ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042313424387a467ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429133401","title":"生物疫苗概念盘中跳水，康希诺跌0.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429133401","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429133401?lang=zh_cn&edition=full","pubTime":"2024-04-23 10:47","pubTimestamp":1713840430,"startTime":"0","endTime":"0","summary":"04月23日，生物疫苗概念盘中跳水，截至10点47分，生物疫苗概念整体指数下跌1.02%，报1839.910点。从个股上来看，该概念的成分股中，康希诺跌0.02%，跌幅居前。从资金上来看，截止发稿，生物疫苗概念主力净流入为-2.10亿，其中神州细胞-U受到资金热捧，主力净流入2184.36万；拉长时间线来看，该板块近20日主力资金净流入-28.01亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423104710861e80bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423104710861e80bf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429182090","title":"南向资金4月22日净买入康希诺生物13.26万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429182090","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429182090?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:31","pubTimestamp":1713835874,"startTime":"0","endTime":"0","summary":"4月22日, 南向资金增持康希诺生物13.26万股，连续7日增持。截止当日收盘，港股通共持有康希诺生物4765.32万股，占流通股35.91%。港股通增持金额前五个股分别为腾讯控股、中国银行、建设银行、中国石油化工股份、中通快递-W。康希诺生物近5个交易日上涨0.57%，港股通累计增持64.88万股；近20个交易日上涨3.43%，港股通累计增持87.48万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309474087a38938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309474087a38938&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429945245","title":"康希诺(688185.SH)：Hib疫苗临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2429945245","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429945245?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:09","pubTimestamp":1713780542,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺(688185.SH)发布公告，公司于近日收到国家药品监督管理局核准签发的关于冻干b型流感嗜血杆菌结合疫苗(简称“Hib疫苗”)的《药物临床试验批准通知书》。公司研发的Hib疫苗系以纯化的Hib荚膜多糖与破伤风类毒素蛋白共价结合而成，采用冻干剂型，预期可在接种后诱导针对Hib的体液免疫，对接种者提供保护作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106639.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429894545","title":"康希诺：\n为关于公司流脑产品就特定内容的进一步补充申报，如有阶段性进展，会及时分享","url":"https://stock-news.laohu8.com/highlight/detail?id=2429894545","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429894545?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:04","pubTimestamp":1713780284,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺04月22日在投资者关系平台上答复投资者关心的问题。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200021586.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429917671","title":"康希诺董秘回复： 基于四价流脑结合疫苗的高端市场定位，销售和市场拓展方面","url":"https://stock-news.laohu8.com/highlight/detail?id=2429917671","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429917671?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:01","pubTimestamp":1713776509,"startTime":"0","endTime":"0","summary":"证券之星消息，康希诺04月22日在投资者关系平台上答复投资者关心的问题。在三四五线城市的下沉商业化中，公司如何考量成本和销量的关系？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221701558b457b34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221701558b457b34&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429993399","title":"【AH互动】康希诺(06185)AH股齐升逾4% 重组肺炎球菌蛋白疫苗I期临床试验取得积极初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2429993399","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2429993399?lang=zh_cn&edition=full","pubTime":"2024-04-22 11:26","pubTimestamp":1713756412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 康希诺生物(06185)早盘反复扬升，截至发稿，报17.32港元，涨4.97%，成交额1207.69万港元。另外，对应A股康希诺(688185)同步走高，暂报47.51元人民币，涨4.51%，成交额5604.76万元人民币。消息面上，公司研发的重组肺炎球菌蛋白疫苗(PBPV)于I期临床试验中获得了积极的初步结果。结果表明，PBPV在成人及老年人群中具有良好的安全性，未观察到3级不良反应和特殊的安全性风险。公司将基于I期临床试验中获得的初步结果，进行下一阶段PBPV研发工作的评估和规划。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/MzBjNmFjYTg0ZGViYjVhMGFmODhkMDhhN2E5MzY4MTQyOTQ2MzQ2MjU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzBjNmFjYTg0ZGViYjVhMGFmODhkMDhhN2E5MzY4MTQyOTQ2MzQ2MjU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935486","is_publish_highlight":false,"gpt_icon":0},{"id":"2429491960","title":"康希诺生物盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429491960","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429491960?lang=zh_cn&edition=full","pubTime":"2024-04-22 11:03","pubTimestamp":1713755003,"startTime":"0","endTime":"0","summary":"2024年04月22日早盘11时03分，康希诺生物股票出现异动，股价快速拉升5.09%。康希诺生物股票所在的生物技术行业中，整体涨幅为0.64%。消息层面，截至11时03分，康希诺生物股票正面舆情新闻比例45.45%。康希诺生物的重组肺炎球菌蛋白疫苗在I期临床试验中取得的积极结果，为该疫苗的进一步研发和应用奠定了坚实基础。未来，康希诺生物将继续携手各方伙伴，致力于推动疫苗研发领域的创新发展，为全球公共卫生事业作出更大贡献。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221103247a54637f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221103247a54637f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429998353","title":"康希诺大幅上涨 近半年3家券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2429998353","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2429998353?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:56","pubTimestamp":1713754611,"startTime":"0","endTime":"0","summary":"04月22日，康希诺股价大幅上涨，截至10点56分，康希诺上涨5.04%，报47.75元/股，成交4410万元，换手率0.82%，振幅5.28%。资金动向截止发稿，康希诺获得主力净流出112万元，其中超大单流出63万元，大单流出47万元。北向资金方面，康希诺04月19日获得北向资金减持7.60万股连续4日减持，截至04月19日，北向资金当前共持有康希诺72.13万股，市值3444万元，持股占流通股比为0.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221056597a54633d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221056597a54633d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429938441","title":"I期临床试验成功！康希诺生物重组肺炎球菌蛋白疫苗研发取得积极成果，为全球疫苗市场带来新希望","url":"https://stock-news.laohu8.com/highlight/detail?id=2429938441","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2429938441?lang=zh_cn&edition=full","pubTime":"2024-04-21 19:40","pubTimestamp":1713699604,"startTime":"0","endTime":"0","summary":"康希诺生物的重组肺炎球菌蛋白疫苗在I期临床试验中取得的积极结果，为该疫苗的进一步研发和应用奠定了坚实基础。此次重组肺炎球菌蛋白疫苗的研发，是康希诺生物在生物医药领域技术积累和创新能力的重要体现。未来，康希诺生物将继续携手各方伙伴，致力于推动疫苗研发领域的创新发展，为全球公共卫生事业作出更大贡献。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404211940088b41e0b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404211940088b41e0b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429875199","title":"1期临床大捷：康希诺重组肺炎球菌蛋白疫苗展现广谱潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2429875199","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2429875199?lang=zh_cn&edition=full","pubTime":"2024-04-21 18:21","pubTimestamp":1713694916,"startTime":"0","endTime":"0","summary":"康希诺公司在4月21日宣布，其在研的重组肺炎球菌蛋白疫苗已在I期临床试验中取得了积极的初步结果。此外，PBPV疫苗的单剂接种能够诱导显著的结合抗体以及针对跨家族/亚类肺炎链球菌的功能性杀菌抗体应答，进一步证明了其广谱性和潜在的公共卫生价值。康希诺的这一成果对于公共卫生领域的疫苗研发具有重要意义，表明了该公司在肺炎疫苗领域的研发实力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404211822018b41b76f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404211822018b41b76f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428579342","title":"南向资金4月18日净买入康希诺生物8.24万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428579342","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428579342?lang=zh_cn&edition=full","pubTime":"2024-04-19 09:31","pubTimestamp":1713490291,"startTime":"0","endTime":"0","summary":"4月18日, 南向资金增持康希诺生物8.24万股，连续5日增持。截止当日收盘，港股通共持有康希诺生物4742.56万股，占流通股35.74%。港股通增持金额前五个股分别为腾讯控股、中国石油股份、中国银行、中国移动、建设银行。康希诺生物近5个交易日下跌3.38%，港股通累计增持91.24万股；近20个交易日上涨1.96%，港股通累计增持92.80万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190944108b384bbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190944108b384bbb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428579324","title":"北向资金4月18日净卖出康希诺1.61万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428579324","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428579324?lang=zh_cn&edition=full","pubTime":"2024-04-19 09:30","pubTimestamp":1713490236,"startTime":"0","endTime":"0","summary":"4月18日，北向资金减持康希诺1.61万股连续3日减持。截止当日收盘，沪股通共持有康希诺79.73万股，占流通股0.69%。沪股通减持金额前五个股分别为中信银行、农业银行、紫金矿业、长江电力、建发股份。康希诺近5个交易日下跌8.33%，沪股通累计减持6.27万股；近20个交易日下跌17.20%，沪股通累计减持55.22万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190935008b384339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190935008b384339&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428365769","title":"康希诺生物盘中异动 下午盘急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428365769","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428365769?lang=zh_cn&edition=full","pubTime":"2024-04-17 14:20","pubTimestamp":1713334801,"startTime":"0","endTime":"0","summary":"2024年04月17日下午盘14时20分，康希诺生物股票出现异动，股价快速上涨5.01%。截至发稿，该股报18.040港元/股，成交量46.83万股，换手率0.35%，振幅4.42%。机构评级方面，在所有5家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康希诺生物股票所在的生物技术行业中，整体涨幅为0.07%。康希诺生物公司简介：许可项目:第三类医疗器械经营;药品生产;药品进出口;药品零售;药品批发;货物进出口;技术进出口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041714200187e8145a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041714200187e8145a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427734811","title":"康希诺04月16日主力资金流出169万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427734811","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427734811?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:18","pubTimestamp":1713251898,"startTime":"0","endTime":"0","summary":"04月16日, 康希诺股价跌4.06%，报收45.59元，成交金额6282万元，换手率1.18%，振幅4.73%，量比0.69。康希诺今日主力资金净流出169万元，连续3日净流出，上一交易日主力净流出352万元，今日环比减少51.99%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为69.23%，平均跌幅为1.60%。该股近5个交易日下跌15.54%，主力资金累计净流出1281万元；近20日主力资金累计净流出2031万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161529108783205c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161529108783205c&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-13","address":"天津市东丽区经济技术开发区西区南大街185号西区生物医药园四层401-420","stockEarnings":[{"period":"1week","weight":0.0845},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.1481},{"period":"6month","weight":-0.3484},{"period":"1year","weight":-0.5082},{"period":"ytd","weight":-0.3384}],"companyName":"康希诺生物股份公司","boardCode":"AI0027","perCapita":"5225股","boardName":"医药制造业","registeredCapital":"24744万元","compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0613},{"period":"6month","weight":0.0235},{"period":"1year","weight":-0.06},{"period":"ytd","weight":0.0382}],"survey":" 康希诺生物股份公司的主营业务是研发、生产和商业化符合中国及国际标准的创新型疫苗。公司主要产品为埃博拉病毒病疫苗、脑膜炎疫苗、百白破疫苗、肺炎疫苗、结核病疫苗、带状疱疹疫苗、新冠肺炎疫苗、腺病毒疫苗、脊髓灰质炎疫苗。公司获得了“天津瞪羚企业卓越创新奖”、“中国最具成长力科技创新型医药企业”、“天津市呼吸道细菌重组及结合疫苗企业重点实验室”等多项荣誉。","serverTime":1714280270609,"listedPrice":209.71,"stockholders":"21964人(较上一季度减少1.26%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺,688185,康希诺股票,康希诺股票老虎,康希诺股票老虎国际,康希诺行情,康希诺股票行情,康希诺股价,康希诺股市,康希诺股票价格,康希诺股票交易,康希诺股票购买,康希诺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺(688185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺(688185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}